Complete Guide to Switching From Wegovy to Mounjaro
Why Switch from 1.7mg Wegovy to Mounjaro at This Stage?
Patients considering switching from 1.7mg Wegovy to Mounjaro are typically approaching maintenance dosing after 13-16 weeks of treatment, making this an ideal time to evaluate long-term options. The 1.7mg dose represents the penultimate step before reaching the 2.4mg maintenance level, so switching now allows you to explore Mounjaro's dual-action mechanism without disrupting your weight management progress. Many patients switch at this stage due to cost considerations, side effect profiles, or simply wanting to optimise their treatment approach for the maintenance phase ahead.
Mounjaro's unique dual-action as both a GLP-1 and GIP receptor agonist may offer different benefits compared to Wegovy's single GLP-1 mechanism, though both are proven effective prescription-only medicines. Your prescriber can determine equivalent dosing when transitioning from 1.7mg Wegovy to Mounjaro, ensuring continuity of treatment. The switch process is straightforward when both medications are available from the same pharmacy, eliminating supply chain complications during your transition period.
1.7mg Wegovy to Mounjaro Pricing Comparison and Savings
Our 1.7mg Wegovy costs £139.99 for a single pen, representing excellent value for patients at this advanced treatment stage. When comparing costs for switching from 1.7mg Wegovy to Mounjaro, patients should consider both immediate pricing and long-term maintenance costs, as different medications may have varying price structures at higher doses. Returning customers benefit from code DOSE25 applied at checkout, maintaining competitive pricing throughout their treatment journey regardless of which medication they choose.
The Elevate Duo bundle combining 1.7mg and 2.4mg Wegovy costs £369.99, providing a smooth transition to maintenance dosing if you decide to continue with Wegovy rather than switch to Mounjaro. This bundle approach ensures uninterrupted treatment while you evaluate your options with your prescriber. For patients committed to switching from 1.7mg Wegovy to Mounjaro, EverydayMeds stocks both medications, allowing seamless transition without changing pharmacy providers or clinical assessment processes.
Clinical Evidence Supporting Your 1.7mg Wegovy to Mounjaro Decision
The STEP trials demonstrated that patients taking Wegovy achieved average weight loss of approximately 15% at 68 weeks when used alongside diet and exercise, with many patients showing significant progress by the 1.7mg dose stage. Mounjaro's SURMOUNT trials showed comparable efficacy with its dual-action mechanism, though direct head-to-head comparisons aren't available due to different trial designs and populations.
When considering switching from 1.7mg Wegovy to Mounjaro, both medications have demonstrated cardiovascular benefits in clinical studies, with Wegovy's SELECT trial showing 20% reduction in major cardiovascular events. Your prescriber will consider your individual response to 1.7mg Wegovy when determining the most appropriate Mounjaro dose equivalent for your transition.
Understanding Wegovy's Mechanism Before Your Switch to Mounjaro
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. This mechanism works on brain appetite centres, potentially reducing food cravings and helping you feel satisfied with appropriate portion sizes. The 1.7mg dose you're currently taking represents significant receptor engagement, providing substantial appetite suppression for most patients. When switching from 1.7mg Wegovy to Mounjaro, you'll transition from this single-pathway approach to Mounjaro's dual GLP-1 and GIP receptor activation. Understanding this mechanism difference helps explain why some patients prefer one medication over another based on their individual response patterns.
Seamless Ordering Process for Your Wegovy to Mounjaro Switch
Switching from 1.7mg Wegovy to Mounjaro through EverydayMeds requires a simple 3-minute online clinical assessment to update your treatment plan. Our prescribers review switch requests within 3 working days (or 24 hours with express service), ensuring safe transition between medications. Once approved, your new Mounjaro prescription arrives via next-day cold-chain delivery, maintaining the same high standards you've experienced with Wegovy. The clinical assessment process considers your current response to 1.7mg Wegovy, any side effects experienced, and your goals for the switch to Mounjaro. This thorough evaluation ensures your transition is both safe and optimally timed for your treatment journey.
Storage Considerations When Switching from 1.7mg Wegovy to Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for 6 weeks at room temperature below 30°C once removed from the fridge, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigeration at 2-8°C before first use, but this storage advantage might influence your decision when switching from 1.7mg Wegovy to Mounjaro, particularly if you travel frequently. The FlexTouch pen system used for Wegovy provides reliable dose delivery, while Mounjaro uses its own injection system with different handling characteristics. Your prescriber will provide specific storage and injection guidance when switching from 1.7mg Wegovy to Mounjaro to ensure optimal medication efficacy. Both are once-weekly injections, maintaining the same convenient dosing schedule you're accustomed to with Wegovy.
Advanced Treatment Stage Considerations for 1.7mg Wegovy to Mounjaro Switch
At the 1.7mg Wegovy stage, you're experiencing your treatment's peak appetite suppression before maintenance dosing, making this an excellent time to evaluate switching to Mounjaro based on your body's response patterns. Patients who've reached 1.7mg typically have good tolerance for GLP-1 medications, suggesting they may also tolerate Mounjaro's dual-action mechanism well. The timing of switching from 1.7mg Wegovy to Mounjaro allows for careful monitoring during the transition without disrupting established weight loss momentum.
Long-term treatment planning becomes crucial at this advanced stage, as you're approaching maintenance therapy that may continue for months or years. Switching from 1.7mg Wegovy to Mounjaro now allows sufficient time to establish tolerance and efficacy before committing to long-term maintenance dosing. Your prescriber will consider factors like cost effectiveness, side effect profiles, and individual response when guiding your switch from 1.7mg Wegovy to Mounjaro at this critical treatment juncture.
Complete Your Switch from 1.7mg Wegovy to Mounjaro Today
Ready to explore switching from 1.7mg Wegovy to Mounjaro? Start your transition with our straightforward clinical assessment at https://everydaymeds.co.uk/collections/weight-loss, where our prescribers will evaluate your current progress and determine the optimal Mounjaro dose equivalent. Returning customers can use code DOSE25 at checkout to maintain their cost savings during the medication transition. Our GPhC-registered pharmacy ensures the same high-quality service whether you choose Wegovy or Mounjaro for your weight management journey. Both medications are prescription-only medicines requiring clinical supervision, and our team provides ongoing support throughout your switching process. Take the next step in optimising your weight management treatment by exploring your options with EverydayMeds today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
